Join a live webinar workshop focused on the Cardiovascular Risks and Effects of Psychedelics
Important Webinar Details
- The live webinar workshop will take place 9am-11:30am Mountain Time on Saturday May 17th
- Includes the live webinar workshop, access to a copy of the video recording, as well as downloadable PDF slides
- The workshop will consist of a 60-75 min lecture, short break, 30-40 min break out group case discussion, and 30 min case review Q&A session
- There will be no refunds issued for the event in the circumstances you're unable to attend
- The recording will be available for viewing 72 hours after the completion of the live event
Workshop Overview:
As the therapeutic and spiritual use of psychedelics gains popularity, it is critical to understand the cardiovascular risks associated with their use, particularly among individuals with pre-existing heart conditions or risk factors. This webinar, led by Dr. Benjamin Malcolm, PharmD, MPH (Spirit Pharmacist), provides a detailed examination of the cardiovascular effects of a range of psychedelics, including tryptamine and ergoline compounds like psilocybin, LSD, and DMT, as well as the dissociative ketamine and phenethylamines such as MDMA.
Participants will gain an evidence-informed framework for cardiovascular screening, learn to assess intrinsic and extrinsic risk factors, and explore pharmacologic mechanisms underlying hemodynamic changes during psychedelic experiences. The session will also address limitations in current clinical trial data, discuss risk profiles across different routes of administration, and highlight harm reduction practices tailored to cardiovascular health.
By integrating observational findings, clinical pharmacology, and practical strategies, this webinar aims to empower clinicians, facilitators, and healthcare practitioners to make informed decisions about candidate eligibility, session preparation, and emergency response planning. Special attention will be given to identifying populations at elevated risk, medication considerations, and best practices for managing acute cardiovascular events in psychedelic settings.
Learning Objectives:
- Outline a systematic rationale for cardiovascular screening prior to psychedelic experiences
- Describe the hemodynamic effects of ketamine and serotonergic psychedelics and their clinical implications
- Recognize key cardiovascular risk factors, stratify risk severity, and assess medication profiles
- Understand emergency preparedness strategies and harm reduction approaches to mitigate cardiovascular complications
- Critically evaluate the gaps in current clinical trial data and their relevance to real-world practice
- Review case example intake forms and discuss their contents
Registration will trigger emails that have the workshop information containing the attendance link. Save this page or link so you can easily revisit.
The attendance link will also be available on the webpage immediately following registration.
It is your responsibility to follow up at [email protected] if you do not receive these emails at least 24 hours prior to the event.
In the case of gross technical difficulties (e.g. power outage, repeated or prolonged internet disruption) or other circumstances (e.g., illness, medical emergency) significantly effecting the workshop quality or precluding its occurrence, the workshop will be rescheduled to a different time.
Webinar Disclaimer
This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.
Host Information
Dr. Ben Malcolm is a psychopharmacology consultant and psychedelic educator. You can learn more about him, his education and training, and career via the about page https://www.spiritpharmacist.com/about